Invacell: Philippe Chavrier and Harald Stenmark labs received grant to collaborate on cancer invasion and metastases research


Philippe Chavrier and his colleagues have received a joint grant with Norwegian researchers from the group of Harald Stenmark from The Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. The funds were donated by Trond S. Paulsen and allocated by The Radium Hospital Foundation to combat cancer cell invasiveness through the project Invacell.

The project is a basic research work that facilitates the development of drugs in the long term that can prevent the spread of metastases. The research will run over four years and contribute to strengthening the long-term cooperation between Norway and France. The project has been created simultaneously with a newly established framework agreement for cancer research between Oslo University Hospital and Institut Curie.

Philippe Chavrier and his colleagues at Institut Curie have long-standing interest in understanding the mechanism of tumor invasion in breast cancer. Their studies on MT1-MMP and invadopodia in breast cancer invasion were crucial contributions to the foundation of the collaboration.